ORGANON & CO.

Lobbying for ORGANON & CO.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $280,000.00 expenses · posted Oct 20, 2025

Lobbying activity 2

Medicare/Medicaid

Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (PL 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing

Budget/Appropriations

FY26 appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.